11/11/2025
ACOG commends HHS for improving access to hormone therapy needed for treatment of menopausal symptoms. ACOG has long called for removal of the black box warning on low-dose vaginal estrogen, and our guidance remains the same: Hormonal treatment should be individualized and based on each patient’s risks and goals. Read our full statement: https://bit.ly/43pChzP